We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Implications of Menopausal Hormone Therapy on Strabismus Incidence and Surgical Outcomes in Postmenopausal Women

MedXY Editorial Team•Oct 8, 2026•news
Menopausal Hormone TherapyMenopauseOcular AlignmentStrabismusstrabismus surgery

Highlight

– Menopausal hormone therapy (MHT) increases the risk of strabismus diagnosis and related strabismus surgeries in menopausal women.
– No association was found between MHT and reoperation rates after primary strabismus surgery.
– The study used a large electronic health record cohort and rigorous time-varying Cox models to adjust for confounding factors.
– These findings suggest hormonal influences on ocular alignment mechanisms in postmenopausal women.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Bridging the Knowledge Gap: Enhancing Menopause Education for CliniciansDespite menopause being a universal experience, many physicians lack adequate training in menopause care, resulting in unmet patient needs and increased reliance on unregulated sources. Medical education reforms are essential to close this Oct 10, 2026Long-Term Recurrence of Hypertropia After Surgery in Sagging Eye Syndrome: Insights and ImplicationsStrabismus surgery effectively corrects hypertropia in sagging eye syndrome (SES), yet about 25% of patients experience delayed recurrent hypertropia over two years, reflecting SES’s progressive nature. Overcorrections are rare and maSep 22, 2026Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women with Vasomotor Symptoms: Insights from the SWAN StudyInitiation of menopausal hormone therapy during perimenopause or early postmenopause in women with vasomotor symptoms is associated with a reduced cardiovascular risk, especially among Black women and those starting therapy within 10 yearsSep 13, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Evaluating Voice Disorder Risks in Peri- and Post-Menopausal Women Using Hormone Replacement Therapy: Insights from a Large TriNetX Cohort
This study investigates the association between peri- and post-menopausal hormone replacement therapy (HRT) and the risk of voice disorders, revealing transiently increased dysphonia risk within the first nine months but no sustained clinic
Sep 7, 2026
Long-Term Outcomes of Strabismus Surgery in Children with Perinatal Brain Injury: Insights and Clinical ImplicationsChildren with perinatal brain injury exhibit lower long-term success rates following strabismus surgery, mainly due to undercorrection despite comparable surgical dosing. Larger preoperative deviations predict poorer outcomes, underscoringAug 24, 2026
Menopausal Transition and Thyroid Function: Deciphering the Impact Beyond Aging in Midlife WomenA comprehensive longitudinal study reveals that menopausal transition does not significantly alter thyroid function beyond normal aging effects in healthy women, clarifying the interplay between menopause and thyroid health.Aug 21, 2026